Holen Sie sich die Stockscreener-App
1.9875
2.45%
-0.0125
Schlusskurs vom Vortag:
$2.00
Offen:
$2
24-Stunden-Volumen:
172.97K
Relative Volume:
0.25
Marktkapitalisierung:
$43.08M
Einnahmen:
$1.38M
Nettoeinkommen (Verlust:
$-179.05M
KGV:
-0.3237
EPS:
-6.14
Netto-Cashflow:
$-155.03M
1W Leistung:
+14.76%
1M Leistung:
-8.40%
6M Leistung:
-2.21%
1J Leistung:
+406.10%
1-Tages-Spanne:
$1.92
$2.02
1-Wochen-Bereich:
$1.70
$2.12
52-Wochen-Spanne:
$0.16
$8.08
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
Firmenname
Bioxcel Therapeutics Inc
Sektor
Telefon
203-643-8060
Adresse
555 LONG WHARF DRIVE, NEW HAVEN, CT
Vergleichen Sie BTAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
1.97 | 43.74M | 1.38M | -179.05M | -155.03M | -6.14 |
|
ZTS
Zoetis Inc
|
126.35 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.33 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.92 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.07 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
50.30 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-21 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-15 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-07-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-03-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-01 | Hochstufung | Goldman | Sell → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-06 | Bestätigt | BofA Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-30 | Eingeleitet | Goldman | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-04 | Eingeleitet | Guggenheim | Buy |
| 2020-04-01 | Eingeleitet | BofA/Merrill | Buy |
| 2020-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Bioxcel Therapeutics Inc Aktie (BTAI) Neueste Nachrichten
Trend Review: How institutional buying supports BioXcel Therapeutics Inc. stockJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - ulpravda.ru
Will BioXcel Therapeutics Inc. stock attract ESG investorsQuarterly Portfolio Summary & Consistent Profit Alerts - ulpravda.ru
Is BioXcel Therapeutics Inc. (BX20) stock undervalued historicallyJuly 2025 Breakouts & Fast Moving Stock Trade Plans - ulpravda.ru
What insider trading reveals about BioXcel Therapeutics Inc. stockTrade Risk Assessment & Fast Entry Momentum Alerts - ulpravda.ru
How robust is BioXcel Therapeutics Inc. (BX20) stock financial positionMACD Histogram Signals & Maximize Returns With Insights - ulpravda.ru
BioXcel Seeks FDA Nod For At-Home Use Of IGALMI In Bipolar And Schizophrenia Agitation - Nasdaq
BioXcel plans FDA submission for at-home agitation treatment By Investing.com - Investing.com Nigeria
BioXcel plans FDA submission for at-home agitation treatment - Investing.com India
BTAI FinancialsIncome Statement - Quiver Quantitative
BioXcel Therapeutics, Inc. Plans Supplemental NDA Submission for IGALMI® Approval for At-Home Use in Treating Agitation Associated with Bipolar Disorders and Schizophrenia - Quiver Quantitative
Drugmaker moves to bring at-home relief for bipolar agitation - Stock Titan
BioXcel Therapeutics enacts 1-for-16 reverse stock split - MSN
BioXcel Therapeutics (BTAI) price target decreased by 26.17% to 16.12 - MSN
Will BioXcel Therapeutics Inc. stock see insider buying2025 Sector Review & Real-Time Chart Breakout Alerts - moha.gov.vn
Vipin Agarwal Net Worth (2025) - GuruFocus
What MACD trends signal for BioXcel Therapeutics Inc. (BX20) stockWeekly Market Report & Community Driven Trade Alerts - Улправда
EPS Watch: How robust is BioXcel Therapeutics Inc. (BX20) stock financial position2025 Earnings Surprises & AI Powered Market Entry Strategies - Улправда
Gap Down: Can BioXcel Therapeutics Inc. stock maintain growth trajectoryWeekly Gains Report & Daily Momentum Trading Reports - Улправда
Can BioXcel Therapeutics Inc. stock maintain growth trajectoryEarnings Overview Summary & Verified Swing Trading Watchlist - Улправда
Risk Off: Will BioXcel Therapeutics Inc. stock see insider buying2025 Growth vs Value & AI Driven Stock Reports - Улправда
BioXcel Therapeutics (BTAI) Stock Analysis Report | Financials & Insights - Benzinga
Loss Report: Will BioXcel Therapeutics Inc. stock see insider buyingJuly 2025 Update & Daily Volume Surge Trade Alerts - Улправда
BioXcel Therapeutics Earnings Notes - Trefis
BioXcel Therapeutics holds annual stockholders meeting - MSN
BioXcel Therapeutics Holds Annual Stockholders Meeting - TipRanks
BioXcel Therapeutics (NASDAQ: BTAI) wins approval for reverse stock split plan - Stock Titan
BTAI: All proposals, including director elections and a reverse split amendment, were approved - TradingView — Track All Markets
BioXcel Therapeutics Inc To Host Virtual Roundtable with Leading Medical Experts Transcript - GuruFocus
Aug Decliners: What MACD trends signal for BioXcel Therapeutics Inc BX20 stockJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - moha.gov.vn
Can BioXcel Therapeutics Inc. (BX20) stock sustain free cash flowQuarterly Growth Report & Weekly High Return Opportunities - Newser
What Analysts Think Is Changing The Story For BioXcel Therapeutics Now - Yahoo Finance
Can BioXcel Therapeutics Inc. stock beat analyst upgrades2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Is BioXcel Therapeutics Inc. (BX20) stock a fit for income portfoliosM&A Rumor & Fast Entry Momentum Alerts - Newser
Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions - The Manila Times
Award-Winning Journalist Anjalee Khemlani to Host Virtual - GlobeNewswire
BioXcel Therapeutics (BTAI) hosts Dec. 8 virtual panel on at-home agitation treatment - Stock Titan
What is the fair value of BioXcel Therapeutics Inc. stock nowJuly 2025 Short Interest & Fast Moving Stock Watchlists - Newser
Is BioXcel Therapeutics Inc. (BX20) stock worth holding before Fed meeting2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Can BioXcel Therapeutics Inc. stock resist market sell offsTrade Volume Report & Technical Pattern Alert System - BỘ NỘI VỤ
FDA Approves New Indication for BioXcel Therapeutics' Igalmi (BT - GuruFocus
Why BioXcel Therapeutics Inc. (BX20) stock could be next leaderMarket Volume Summary & AI Enhanced Trading Alerts - newser.com
Can BioXcel Therapeutics Inc. stock deliver consistent earnings growthEarnings Recap Summary & Consistent Return Investment Signals - newser.com
Is BioXcel Therapeutics Inc. stock attractive after correctionQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com
Why BioXcel Therapeutics Inc. (BX20) stock is listed among top recommendationsEarnings Recap Summary & Fast Entry Momentum Trade Alerts - newser.com
Will BioXcel Therapeutics Inc. stock see PE expansionJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Can BioXcel Therapeutics Inc. stock beat market expectations this quarterTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
BioXcel Therapeutics Inc. (BTAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is BioXcel Therapeutics Inc. (BX20) stock vulnerable to rate hikesChart Signals & Daily Entry Point Alerts - newser.com
Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):